What is she best known for?
The fields of study she is best known for:
- Statistics
- Internal medicine
- Gene
Her primary areas of study are Pathology, Internal medicine, Alzheimer's disease, Surgery and Oncology.
Her studies deal with areas such as Magnetic resonance imaging and Central nervous system disease as well as Pathology.
Her research brings together the fields of Endocrinology and Internal medicine.
Her work deals with themes such as Apolipoprotein E, Dementia and Neurodegeneration, which intersect with Alzheimer's disease.
When carried out as part of a general Surgery research project, her work on Perineum is frequently linked to work in Lung injury, therefore connecting diverse disciplines of study.
Her biological study spans a wide range of topics, including Aging brain, Cognition, Disease and Cognitive decline.
Her most cited work include:
- Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. (823 citations)
- Tau positron emission tomographic imaging in aging and early Alzheimer disease (527 citations)
- Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease (506 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Statistics, Pathology, Oncology and Econometrics.
Her research integrates issues of Gastroenterology, Endocrinology and Surgery in her study of Internal medicine.
Her Statistics study is mostly concerned with Covariate, Regression analysis, Censoring, Estimator and Sample size determination.
Many of her studies involve connections with topics such as Central nervous system disease and Pathology.
Her Econometrics study integrates concerns from other disciplines, such as Clinical trial and Survival analysis.
Rebecca A. Betensky combines subjects such as Apolipoprotein E and Dementia with her study of Alzheimer's disease.
She most often published in these fields:
- Internal medicine (22.64%)
- Statistics (22.01%)
- Pathology (20.13%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (22.64%)
- Statistics (22.01%)
- Disease (8.18%)
In recent papers she was focusing on the following fields of study:
Rebecca A. Betensky mainly focuses on Internal medicine, Statistics, Disease, Oncology and Proportional hazards model.
Her Internal medicine research incorporates elements of Gastroenterology and Anxiety.
Her Disease research is multidisciplinary, incorporating perspectives in Clinical trial, Diabetes mellitus, Cognition, Immunology and Biomarker.
Her Cognition study combines topics in areas such as Alzheimer's disease, Randomized controlled trial, Dementia and Mediation.
The study incorporates disciplines such as Glioblastoma, Temozolomide, Allele, Cognitive decline and Prospective cohort study in addition to Oncology.
Her Cognitive decline research is multidisciplinary, relying on both Neuropathology and Amyloid.
Between 2017 and 2021, her most popular works were:
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (148 citations)
- Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. (95 citations)
- The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals (75 citations)
In her most recent research, the most cited papers focused on:
- Statistics
- Internal medicine
- Gene
Rebecca A. Betensky mostly deals with Internal medicine, Dementia, Disease, Cognition and Oncology.
Her research links Allele with Internal medicine.
Rebecca A. Betensky has researched Dementia in several fields, including Alzheimer's disease, Single-nucleotide polymorphism, Bioinformatics and Mediation.
Her studies deal with areas such as Hyperintensity, Family history, Lifestyle factors and Health professionals as well as Disease.
Her work carried out in the field of Cognition brings together such families of science as Pathological, Amygdala, Depression and Anxiety.
Her Oncology research includes elements of Relative risk, Parkinson's disease and Caffeine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
